- 1101. Carboplatin/Filgrastim/Interleukin-6/Paclitaxel
- (UMLS (NCI) C0281614) =Therapeutic or Preventive Procedure
| - 1151. Carboplatin/Paclitaxel/SCH-58500
- (UMLS (NCI) C0796609) CBDCA/SCH-58500/TAX =Therapeutic or Preventive Procedure
|
- 1102. Carboplatin/Filgrastim/Paclitaxel
- (UMLS (NCI) C0281546) =Therapeutic or Preventive Procedure
| - 1152. Carboplatin/Paclitaxel/Suramin
- (UMLS (NCI) C0935740) =Therapeutic or Preventive Procedure
|
- 1103. Carboplatin/filgrastim/Paclitaxel/Topotecan
- (UMLS (NCI) C0338368) =Therapeutic or Preventive Procedure
| - 1153. Carboplatin/Paclitaxel/Thalidomide
- (UMLS (NCI) C0879261) =Therapeutic or Preventive Procedure
|
- 1104. Carboplatin/Filgrastim/Topotecan
- (UMLS (NCI) C0281528) =Therapeutic or Preventive Procedure
| - 1154. Carboplatin/Paclitaxel/Tirapazamine
- (UMLS (NCI) C0879465) =Therapeutic or Preventive Procedure ;
|
- 1105. Carboplatin/Flavopiridol
- (UMLS (NCI) C1134468) =Therapeutic or Preventive Procedure
| - 1155. Carboplatin/Paclitaxel/Topotecan
- (UMLS (NCI) C0338367) =Therapeutic or Preventive Procedure
|
- 1106. Carboplatin/Floxuridine
- (UMLS (NCI) C0677825) =Therapeutic or Preventive Procedure ;
| - 1156. Carboplatin/Pemetrexed Disodium
- (UMLS (NCI) C1327967) =Therapeutic or Preventive Procedure ;
|
- 1107. Carboplatin/Fludarabine
- (UMLS (NCI) C0879482) =Therapeutic or Preventive Procedure
| - 1157. Carboplatin/Pentoxifylline
- (UMLS (NCI) C0281591) =Therapeutic or Preventive Procedure
|
- 1108. Carboplatin/Fludarabine/Thalidomide/Topotecan
- (UMLS (NCI) C1327860) =Therapeutic or Preventive Procedure
| - 1158. Carboplatin/Polyglutamate Paclitaxel
- (UMLS (NCI) C1327870) =Therapeutic or Preventive Procedure ;
|
- 1109. Carboplatin/Fluorouracil
- (UMLS (NCI) C0278893) =Therapeutic or Preventive Procedure
| - 1159. Carboplatin/Pyrazoloacridine
- (UMLS (NCI) C0879550) =Therapeutic or Preventive Procedure
|
- 1110. Carboplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium
- (UMLS (NCI) C0280925) =Therapeutic or Preventive Procedure
| - 1160. Carboplatin/Sargramostim
- (UMLS (NCI) C0279204) =Therapeutic or Preventive Procedure
|
- 1111. Carboplatin/Fluorouracil/Leucovorin Calcium
- (UMLS (NCI) C1327782) =Therapeutic or Preventive Procedure ;
| - 1161. Carboplatin/Squalamine Lactate
- (UMLS (NCI) C0935911) =Therapeutic or Preventive Procedure
|
- 1112. Carboplatin/Fluorouracil/Methotrexate
- (UMLS (NCI) C0280619) =Therapeutic or Preventive Procedure
| - 1162. Carboplatin/SU5416
- (UMLS (NCI) C0935697) =Therapeutic or Preventive Procedure
|
- 1113. Carboplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C0935713) =Therapeutic or Preventive Procedure
| - 1163. Carboplatin/Temozolomide
- (UMLS (NCI) C0796490) CBDCA/TMZ;
=Therapeutic or Preventive Procedure ;
|
- 1114. Carboplatin/Fluorouracil/Procarbazine
- (UMLS (NCI) C0280901) =Therapeutic or Preventive Procedure
| - 1164. Carboplatin/Temozolomide/Thiotepa
- (UMLS (NCI) C1134496) =Therapeutic or Preventive Procedure
|
- 1115. Carboplatin/Fluorouracil/Vincristine
- (UMLS (NCI) C0281456) =Therapeutic or Preventive Procedure ;
| - 1165. Carboplatin/Temozolomide/Vincristine
- (UMLS (NCI) C0935663) =Therapeutic or Preventive Procedure
|
- 1116. Carboplatin/Gefitinib/Paclitaxel
- (UMLS (NCI) C0879490) =Therapeutic or Preventive Procedure
| - 1166. Carboplatin/Thalidomide
- (UMLS (NCI) C0678067) =Therapeutic or Preventive Procedure ;
|
- 1117. Carboplatin/Gemcitabine
- (UMLS (NCI) C0796403) CBDCA/dFdC;
=Therapeutic or Preventive Procedure | - 1167. Carboplatin/Thiotepa
- (UMLS (NCI) C0281405) =Therapeutic or Preventive Procedure ;
|
- 1118. Carboplatin/Gemcitabine/Paclitaxel
- (UMLS (NCI) C0678088) =Therapeutic or Preventive Procedure
| - 1168. Carboplatin/Thiotepa/Topotecan
- (UMLS (NCI) C0677976) =Therapeutic or Preventive Procedure
|
- 1119. Carboplatin/Gemcitabine/Paclitaxel/Trastuzumab
- (UMLS (NCI) C0879511) =Therapeutic or Preventive Procedure ;
| - 1169. Carboplatin/Thiotepa/Vincristine
- (UMLS (NCI) C0796631) CBDCA/TSPA/VCR =Therapeutic or Preventive Procedure
|
- 1120. Carboplatin/Gemcitabine/Zileuton
- (UMLS (NCI) C1328065) =Therapeutic or Preventive Procedure; ;
| - 1170. Carboplatin/Thymidine
- (UMLS (NCI) C0281275) =Therapeutic or Preventive Procedure
|
- 1121. Carboplatin/Ifosfamide
- (UMLS (NCI) C0280103) =Therapeutic or Preventive Procedure
| - 1171. Carboplatin/Topotecan
- (UMLS (NCI) C0281513) =Therapeutic or Preventive Procedure
|
- 1122. carboplatin/ifosfamide/mercaptoethane sulfonate
- (UMLS (NCI) C0393055) =Therapeutic or Preventive Procedure
| - 1172. Carboplatin/UCN-01
- (UMLS (NCI) C1134646) =Therapeutic or Preventive Procedure
|
- 1123. Carboplatin/Ifosfamide/Paclitaxel
- (UMLS (NCI) C0392956) =Therapeutic or Preventive Procedure
| - 1173. Carboplatin/Vinblastine
- (UMLS (NCI) C0280517) =Therapeutic or Preventive Procedure ;
|
- 1124. Carboplatin/Ifosfamide/Sargramostim
- (UMLS (NCI) C0280996) =Therapeutic or Preventive Procedure
| - 1174. Carboplatin/Vincristine
- (UMLS (NCI) C0280102) =Therapeutic or Preventive Procedure
|
- 1125. Carboplatin/Ifosfamide/Thiotepa
- (UMLS (NCI) C0879374) =Therapeutic or Preventive Procedure
| - 1175. Carboplatin/Vinorelbine
- (UMLS (NCI) C0879344) =Therapeutic or Preventive Procedure
|
- 1126. Carboplatin/Ifosfamide/Vincristine
- (UMLS (NCI) C0279230) =Therapeutic or Preventive Procedure ;
| - 1176. carbopolycyclic compound
- [Hydrocarbons consisting of two or more fused ring structures. ( MSH )] (UMLS (CSP) C0032457) =Organic Chemical ;
=cyclic compound;
active ingredient =AAF;
anthracene;
benzanthracene;
chrysene;
methylcholanthrene;
naphthalene;
phenanthrene;
pyrene;
Steroid;
suramin;
Bridged Compounds;
PAH;
Steroid |
- 1127. Carboplatin/IM-862/Paclitaxel
- (UMLS (NCI) C0935864) =Therapeutic or Preventive Procedure ;
| - 1177. CARBOPROST
- [A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of PREGNANCY. ( MSH )] (UMLS (NCI) C0007047) =Eicosanoid; Pharmacologic Substance ;
=[HS875] PROSTAGLANDINS;
Prostaglandins F, Synthetic =Carboprost 0.25 MG/ML;
|
- 1128. Carboplatin/Interferon Alfa
- (UMLS (NCI) C0338135) =Therapeutic or Preventive Procedure
| - 1178. Carboptic
- (UMLS (NCI) C0719159) =Organic Chemical; Pharmacologic Substance ;
|
- 1129. Carboplatin/Interleukin-1-Alpha
- (UMLS (NCI) C0280884) =Therapeutic or Preventive Procedure
| - 1179. Carboquone
- [An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. ( MSH )] (UMLS (NCI) C0006971) =Organic Chemical; Pharmacologic Substance
|
- 1130. Carboplatin/Interleukin-1-Alpha/Methylene Blue
- (UMLS (NCI) C0281362) =Therapeutic or Preventive Procedure
| - 1180. carborane
- [ ] (UMLS (CSP) C0598027) =Inorganic Chemical ;
|
- 1131. Carboplatin/Interleukin-3
- (UMLS (NCI) C0280923) =Therapeutic or Preventive Procedure
| - 1181. Carboxy
- [monovalent radical -COOH in carboxylic acids. ( CSP )] (UMLS (NCI) C0596260) =Organic Chemical ;
=chemical group;
|
- 1132. Carboplatin/Interleukin-6/Sargramostim
- (UMLS (NCI) C0281527) =Therapeutic or Preventive Procedure
| - 1182. carboxy lyase
- [enzymes which catalyze the nonhydrolytic removal of carbon dioxide from carboxylic acids. ( CSP )] (UMLS (CSP) C0007054) =Amino Acid, Peptide, or Protein; Enzyme ;
=carbon carbon lyase;
=glutamate decarboxylase;
histidine decarboxylase;
ODC;
PEPCK;
alpha carboxylase;
aromatic L aminoacid decarboxylase |
- 1133. Carboplatin/Irinotecan
- (UMLS (NCI) C0935781) =Therapeutic or Preventive Procedure ;
| - 1183. Carboxy-Terminal Domain RNA Polymerase II Polypeptide A Small Phosphatase 2
- [Ubiquitously expressed (highest in pancreas, lowest in liver) by human OS4 Gene (NIF Family), 283-aa 32-kDa Nuclear LIM Interactor-Interacting Factor 2 is a phosphatase that may interact with LDB1. ( NCI )] (UMLS (NCI) C1335071) CTD;
CTDSP2;
NIF2;
NLI-Interacting Factor 2;
Nuclear LIM Interactor-Interacting Factor 2;
OS4;
Protein OS-4;
SCP2;
Small CTD Phosphatase 2 =Amino Acid, Peptide, or Protein; Enzyme |
- 1134. Carboplatin/Irinotecan/Thalidomide
- (UMLS (NCI) C1134491) =Therapeutic or Preventive Procedure
| - 1184. Carboxycinnamic Acid Bishydroxamide
- [A hybrid polar compound that induces terminal differentiation and/or apoptosis in various transformed cells. It is an inhibitor of histone deacetylase. ( NCI )] (UMLS (NCI) C0672711) =Organic Chemical; Pharmacologic Substance ;
|
- 1135. Carboplatin/Irinotecan/Vincristine
- (UMLS (NCI) C1328146) =Therapeutic or Preventive Procedure ;
| - 1185. carboxyhemoglobin
- [hemoglobin in which the sites usually bound to oxygen are bound to carbon monoxide. ( CSP )] (UMLS (CSP) C0007061) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=hemoglobin;
|
- 1136. Carboplatin/ISIS 3521/Paclitaxel
- (UMLS (NCI) C0935863) =Therapeutic or Preventive Procedure ;
| - 1186. carboxylate
- [organic compounds containing the carboxyl group (-COOH) or their salts, esters or conjugate bases. ( CSP )] (UMLS (CSP) C0178528) =Organic Chemical ;
=organic acid;
carbonyl compound =Fatty Acid;
formate;
GEMFIBROZIL;
Keto Acids;
2 propylvalerate;
dicarboxylate;
tricarboxylate;
cyclic acid;
enolate;
|
- 1137. Carboplatin/Ixabepilone
- (UMLS (NCI) C1134546) =Therapeutic or Preventive Procedure
| - 1187. carboxylation
- [addition of carbon dioxide or bicarbonate to form a carboxyl group. ( CSP )] (UMLS (CSP) C0178529) =Natural Phenomenon or Process ;
=chemical reaction;
|
- 1138. Carboplatin/Ixabepilone/Trastuzumab
- (UMLS (NCI) C1328152) =Therapeutic or Preventive Procedure; ;
| - 1188. carboxylesterase
- [Carboxylesterase is a serine-dependent esterase with wide substrate specificity. The enzyme is involved in the detoxification of XENOBIOTICS and the activation of ester and of amide PRODRUGS. ( MSH )] (UMLS (CSP) C0054741) =Amino Acid, Peptide, or Protein; Enzyme ;
=Ester Hydrolase;
=acetylcholine acetylhydrolase;
cholesterol esterase;
choline esterase II;
lipase;
clearing factor lipase;
2 lysophosphatidylcholine acylhydrolase;
EC 3.1.1.4 |
- 1139. Carboplatin/Lobradimil
- (UMLS (NCI) C0338266) =Therapeutic or Preventive Procedure
| - 1189. Carboxylic Acids
- [Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. ( MSH )] (UMLS (NCI) C0007066) =Organic Chemical ;
=Organic Chemical;
=Acids, Acyclic;
Acids, Aldehydic;
Acids, Carbocyclic;
Hydroxy Acids;
Keto Acids;
|
- 1140. Carboplatin/Lomustine/Procarbazine/Vincristine
- (UMLS (NCI) C0678064) =Therapeutic or Preventive Procedure ;
| - 1190. carboxyltransferase
- [ ] (UMLS (CSP) C0524995) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1141. Carboplatin/Melphalan
- (UMLS (NCI) C0796461) CBDCA/L-PAM;
=Therapeutic or Preventive Procedure | - 1191. carboxyltransferase/carbamoyltransferase
- [carboxyltransferase and carbamoyltransferase may be replaced by transcarboxylase and transcarbamoylase respectively. ( CSP )] (UMLS (CSP) C0524996) =Amino Acid, Peptide, or Protein; Enzyme =1 carbon transferase;
=aspartate carbamoyltransferase;
citrulline phosphorylase |
- 1142. Carboplatin/Methotrexate/Vinblastine
- (UMLS (NCI) C0935816) =Therapeutic or Preventive Procedure
| - 1192. carboxymethylation
- [ ] (UMLS (CSP) C0596262) =Phenomenon or Process ;
|
- 1143. Carboplatin/Milodistim
- (UMLS (NCI) C0281233) =Therapeutic or Preventive Procedure ;
| - 1193. carboxymethylcellulose chromatography
- [ ] (UMLS (CSP) C0598729) =Laboratory Procedure ;
|
- 1144. Carboplatin/Milodistim/Paclitaxel
- (UMLS (NCI) C0281648) =Therapeutic or Preventive Procedure ;
| - 1194. carboxypeptidase
- [Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. They are further divided based on their catalytic mechanism into serine-type carboxypeptidases EC 3.4.16; metallocarboxypeptidases, EC 3.4.17; and cysteine-type carboxypeptidases, EC 3.4.18. EC 3.4.-. ( MSH )] (UMLS (CSP) C0007075) =Amino Acid, Peptide, or Protein; Enzyme =exopeptidase;
|
- 1145. Carboplatin/Mitoxantrone
- (UMLS (NCI) C0280810) =Therapeutic or Preventive Procedure ;
| - 1195. Carboxypeptidase G2
- [A bacterial enzyme that belongs to the family of drugs called chemoprotective agents. It is used to neutralize the toxic effects of methotrexate. ( NCI )] (UMLS (NCI) C0007072) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1146. Carboplatin/Monoclonal Antibody ABX-EGF/Paclitaxel
- (UMLS (NCI) C1328036) =Therapeutic or Preventive Procedure; ;
| - 1196. Carboxypeptidase-G2/Leucovorin Calcium/Methotrexate
- (UMLS (NCI) C0281480) =Therapeutic or Preventive Procedure
|
- 1147. Carboplatin/Monoclonal Antibody HER2/Paclitaxel
- (UMLS (NCI) C0796408) Carboplatin/Paclitaxel/Trastuzumab;
CBDCA/MOAB HER2/TAX;
=Therapeutic or Preventive Procedure | - 1197. Carbuncle
- (UMLS (HL7) C1546571) =Intellectual Product =Specimen Source Codes;
|
- 1148. Carboplatin/Oblimersen/Paclitaxel
- (UMLS (NCI) C1327875) =Therapeutic or Preventive Procedure ;
| - 1198. Carbuncle and furuncle of buttock
- [ ] (UMLS (ICD9CM) C0157686) =Disease or Syndrome
|
- 1149. Carboplatin/Paclitaxel
- (UMLS (NCI) C0281297) =Therapeutic or Preventive Procedure
| - 1199. Carbuncle and furuncle of face
- [ ] (UMLS (ICD9CM) C0157681) =Disease or Syndrome
|
- 1150. Carboplatin/Paclitaxel/PSC 833
- (UMLS (NCI) C0796502) CBDCA/PSC 833/TAX;
=Therapeutic or Preventive Procedure ;
| - 1200. Carbuncle and furuncle of foot
- [ ] (UMLS (ICD9CM) C0157688) =Disease or Syndrome
|
home
